Efficacy and safety of exenatide once weekly versus liraglutide in subjects with type 2 diabetes (DURATION-6): a randomised, open-label study [abstract 75]
The anti-obesity medication (AOM) marketplace is rapidly expanding, with analysts estimating it to be worth $150 billion by 2032, fueled by the increasing demand for effective weight management (e.g., 15-25% weight loss) and metabolic health solutions
Sublingual tirzepatide with additives: B12, niacinamide, and more Some compounding pharmacies add complementary ingredients to their sublingual tirzepatide formulations
Increasingly, were learning GLP-1 RAs have an important role in managing a common set of chronic diseases called CKM, or cardiovascular-kidney-metabolic syndrome [archived link]
Injectable tirzepatide has a longer track record in clinical research
11 kg body weight reduction in the SURPASS-4 trial), preserve the eGFR slope and reduce the UACR [57, 58]